Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Other Non-Current Liabilities (2024 - 2025)

Historic Other Non-Current Liabilities for Century Therapeutics (IPSC) over the last 2 years, with Q3 2025 value amounting to $784000.0.

  • Century Therapeutics' Other Non-Current Liabilities fell 9127.24% to $784000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $784000.0, marking a year-over-year decrease of 9127.24%. This contributed to the annual value of $8.7 million for FY2024, which is N/A changed from last year.
  • Per Century Therapeutics' latest filing, its Other Non-Current Liabilities stood at $784000.0 for Q3 2025, which was down 9127.24% from $8.9 million recorded in Q2 2025.
  • Century Therapeutics' Other Non-Current Liabilities' 5-year high stood at $9.3 million during Q2 2024, with a 5-year trough of $20000.0 in Q1 2024.